William Mack & Associates
GH icon

William Mack & Associates’s Guardant Health GH Stock Holding History

William Mack & Associates’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$892 Buy
+5
New +$817 ﹤0.01% 749

Other funds holding GH

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

William Mack & Associates's GH Position: Q3 2026 in Review

William Mack & Associates opened a new position in Guardant Health (GH) in Q3 2026: 5 shares worth $892. The stake represents ﹤0.01% of the portfolio and ranks #749 among its holdings.

511 funds tracked by Wall St. Rank hold GH as of Q3 2026.

  • William Mack & Associates held 5 shares of Guardant Health worth $892 as of Q3 2026.
  • Guardant Health was a new William Mack & Associates position in Q3 2026.
  • Guardant Health made up ﹤0.01% of William Mack & Associates's portfolio in Q3 2026, its #749 holding.
  • 511 funds tracked by Wall St. Rank held Guardant Health as of Q3 2026.

Based on William Mack & Associates's 13F filing for Q3 2026, filed 27 Oct 2026.